Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Helicobacter Infections 2 Gastroesophageal Reflux 2 Breast Neoplasms 2 Barrett Esophagus 2 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Compression 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Persistence of Infection With Helicobacter Pylori 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-Erosive Reflux Disease 1 Neoplasm Metastasis 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Hodgkin Disease 1 Hemorrhage 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastritis, Atrophic 1 Fatigue 1 Familial primary gastric lymphoma 1 Esophageal Neoplasms 1 Delayed Bleeding 1

Interventions

Cisplatin 161 Fluorouracil 135 Paclitaxel 127 Radiotherapy 125 Oxaliplatin 88 Carboplatin 72 Docetaxel 71 Irinotecan 60 pembrolizumab 57 Leucovorin 57 Capecitabine 57 Radiation 48 Esophagectomy 44 Surgical Procedures, Operative 42 Drug Therapy 38 Neoadjuvant Therapy 28 Cetuximab 25 Nivolumab 24 Bevacizumab 21 camrelizumab 20 Trastuzumab 20 S 1 (combination) 19 Chemoradiotherapy 19 Magnetic Resonance Spectroscopy 18 Epirubicin 16 Albumin-Bound Paclitaxel 16 Blood Specimen Collection 15 tislelizumab 14 Taxes 14 Radiotherapy, Intensity-Modulated 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Proton Pump Inhibitors × Clear all

NCT05688761 2024-06-24

NordGETS

Karolinska Institutet

900,000 enrolled

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡